BRILLANTI, STEFANO
BRILLANTI, STEFANO
Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze
A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy
2021-01-01 Frazzoni, Leonardo; Sikandar, Usama; Mazzella, Giuseppe; Fuccio, Lorenzo; Bazzoli, Franco; Brillanti, Stefano; Azzaroli, Francesco
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C
1994-01-01 Brillanti, Stefano; Garson, Jeremy; Foli, Mauro; Whitby, Kevin; Deaville, Robert; Masci, Caterina; Miglioli, Mario; Barbara, Luigi
Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis
1999-01-01 Gramantieri, L; Chieco, P; Di Tomaso, M; Masi, L; Piscaglia, F; Brillanti, S; Gaiani, S; Valgimigli, M; Mazziotti, A; Bolondi, L
Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C
1995-01-01 Garson, J. A.; Brillanti, S.; Whitby, K.; Foli, M; Deaville, R.; Masci, C.; Miglioli, M.; Barbara, L.
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C
2012-01-01 Loggi, Elisabetta; Scuteri, Alessandra; MARTELLO PANNO, Arianna; Grandini, Elena; Cursaro, C.; Margotti, Marzia; Foglianti, G.; Bernardi, Mauro; Brillanti, Stefano; Andreone, Pietro
Cell renewal and cancer risk of the stomach: Analysis of cell proliferation kinetics in atrophic gastritis
1989-01-01 Biasco, G; Paganelli, Gm; Brillanti, S; Lalli, Aa; Brandi, G; Terranova, A; Miglioli, M; Barbara, L
Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience
1995-01-01 Brillanti, S; Miglioli, M; Barbara, L
Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?”
2021-01-01 Capecchi, P. L.; Lazzerini, P. E.; Brillanti, S.
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS
2016-01-01 Buonfiglioli, F; Conti, F; Andreone, P; Crespi, C; Foschi, Fg; Lenzi, M; Mazzella, G; Verucchi, G; Brillanti, S
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice
2016-01-01 Conti, F.; Scuteri, Alessandra; Vitale, G.; Lazzarini, G.; Porro, A.; Muratori, P.; Serio, Ilaria; Buonfiglioli, Federica; Badia, L.; Lanzi, A.; Mastroroberto, Marianna; Appolloni, L.; Morotti, Marta; Morelli, M. C.; Foschi, F. G.; Verucchi, Gabriella; Brillanti, Stefano; Crespi, C.; Lenzi, M.; Mazzella, Giuseppe; Andreone, P.
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum
2018-01-01 Buonfiglioli, Federica; Brillanti, Stefano
Distribution of three major hepatitis C virus genotypes in Italy. A multicentre study of 49 5 patients with chronic hepatitis C
1995-01-01 Pontisso, P; Ruvoletto, Mg; Nicoletti, M; Tisminetzky, S; Gerotto, M; Levrero, M; Artini, M; Baldi, M; Ballardini, G; Barbara, L; Bonetti, P; Brillanti, S; Casarin, C; Chemello, L; Costanzo, A; Demitri, Ms; Donada, C; Felaco, Mf; Frezza, M; Gaeta, Gb; Giostra, F; Iervese, T; Loiacono, O; Milella, M; Monno, L; Negro, F; Piccinino, F; Russo, G; Vaccaro, A; Baralle, F; Alberti, A
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
2016-01-01 Conti, Fabio; Buonfiglioli, Federica; Scuteri, Alessandra; Crespi, Cristina; Bolondi, Luigi; Caraceni, Paolo; Foschi, Francesco Giuseppe; Lenzi, Marco; Mazzella, Giuseppe; Verucchi, Gabriella; Andreone, Pietro; Brillanti, Stefano
EFFECT OF LACTOBACILLUS ACIDOPHILUS AND BIFIDOBACTERIUM BIFIDUM ON RECTAL CELL-KINETICS AND FECAL PH
1991-01-01 Biasco, G; Paganelli, Gm; Brandi, G; Brillanti, S; Lami, F; Callegari, C; Gizzi, G
Effect of α‐interferon therapy on hepatitis C viraemia in community‐acquired chronic non‐A, non‐B hepatitis: A quantitative polymerase chain reaction study
1991-01-01 Brillanti, S.; Garson, J. A.; Tuke, P. W.; Ring, C.; Briggs, M.; Masci, C.; Miglioli, M.; Barbara, L.; Tedder, R. S.
Enhanced response to peginterferon-alpha-2a based triple therapy in previously non-responsive chronic hepatitis C: Final results of PRETTY study
2005-01-01 Mangia, A.; Cimino, L.; Persico, M.; Demelia, L.; Rumi, M.; Spinzi, G.; Fatuzzo, F.; Levrero, M.; Frugiuele, P. L.; Fornaciari, G.; De Stefano, G.; Venturoni, L.; Roda, Enrico; Brillanti, Stefano
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues—A Delphi Consensus Project
2022-01-01 Borghi, C.; Ciancio, A.; Gentile, I.; Perrone Filardi, P.; Pasqualetti, P.; Brillanti, S.
HCV INFECTION AND CHRONIC ACTIVE HEPATITIS IN ALCOHOLICS
1992-01-01 Brillanti, S; Masci, C; Siringo, S; Difebo, G; Miglioli, M; Barbara, L
Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis
1992-01-01 Garson, J. A.; Brillanti, S.; Ring, C.; Perini, P.; Miglioli, M.; Barbara, L.
HEPATITIS-C VIRUS - A POSSIBLE CAUSE OF CHRONIC HEPATITIS IN ALCOHOLICS
1989-01-01 Brillanti, S; Barbara, L; Miglioli, M; Bonino, F
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy | 1-gen-2021 | Frazzoni, Leonardo; Sikandar, Usama; Mazzella, Giuseppe; Fuccio, Lorenzo; Bazzoli, Franco; Brillanti, Stefano; Azzaroli, Francesco | - | |
| A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C | 1-gen-1994 | Brillanti, Stefano; Garson, Jeremy; Foli, Mauro; Whitby, Kevin; Deaville, Robert; Masci, Caterina; Miglioli, Mario; Barbara, Luigi | - | |
| Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis | 1-gen-1999 | Gramantieri, L; Chieco, P; Di Tomaso, M; Masi, L; Piscaglia, F; Brillanti, S; Gaiani, S; Valgimigli, M; Mazziotti, A; Bolondi, L | - | |
| Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C | 1-gen-1995 | Garson, J. A.; Brillanti, S.; Whitby, K.; Foli, M; Deaville, R.; Masci, C.; Miglioli, M.; Barbara, L. | - | |
| Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C | 1-gen-2012 | Loggi, Elisabetta; Scuteri, Alessandra; MARTELLO PANNO, Arianna; Grandini, Elena; Cursaro, C.; Margotti, Marzia; Foglianti, G.; Bernardi, Mauro; Brillanti, Stefano; Andreone, Pietro | - | |
| Cell renewal and cancer risk of the stomach: Analysis of cell proliferation kinetics in atrophic gastritis | 1-gen-1989 | Biasco, G; Paganelli, Gm; Brillanti, S; Lalli, Aa; Brandi, G; Terranova, A; Miglioli, M; Barbara, L | - | |
| Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience | 1-gen-1995 | Brillanti, S; Miglioli, M; Barbara, L | - | |
| Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?” | 1-gen-2021 | Capecchi, P. L.; Lazzerini, P. E.; Brillanti, S. | - | |
| DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS | 1-gen-2016 | Buonfiglioli, F; Conti, F; Andreone, P; Crespi, C; Foschi, Fg; Lenzi, M; Mazzella, G; Verucchi, G; Brillanti, S | - | |
| Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice | 1-gen-2016 | Conti, F.; Scuteri, Alessandra; Vitale, G.; Lazzarini, G.; Porro, A.; Muratori, P.; Serio, Ilaria; Buonfiglioli, Federica; Badia, L.; Lanzi, A.; Mastroroberto, Marianna; Appolloni, L.; Morotti, Marta; Morelli, M. C.; Foschi, F. G.; Verucchi, Gabriella; Brillanti, Stefano; Crespi, C.; Lenzi, M.; Mazzella, Giuseppe; Andreone, P. | - | |
| Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum | 1-gen-2018 | Buonfiglioli, Federica; Brillanti, Stefano | - | |
| Distribution of three major hepatitis C virus genotypes in Italy. A multicentre study of 49 5 patients with chronic hepatitis C | 1-gen-1995 | Pontisso, P; Ruvoletto, Mg; Nicoletti, M; Tisminetzky, S; Gerotto, M; Levrero, M; Artini, M; Baldi, M; Ballardini, G; Barbara, L; Bonetti, P; Brillanti, S; Casarin, C; Chemello, L; Costanzo, A; Demitri, Ms; Donada, C; Felaco, Mf; Frezza, M; Gaeta, Gb; Giostra, F; Iervese, T; Loiacono, O; Milella, M; Monno, L; Negro, F; Piccinino, F; Russo, G; Vaccaro, A; Baralle, F; Alberti, A | - | |
| Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals | 1-gen-2016 | Conti, Fabio; Buonfiglioli, Federica; Scuteri, Alessandra; Crespi, Cristina; Bolondi, Luigi; Caraceni, Paolo; Foschi, Francesco Giuseppe; Lenzi, Marco; Mazzella, Giuseppe; Verucchi, Gabriella; Andreone, Pietro; Brillanti, Stefano | - | |
| EFFECT OF LACTOBACILLUS ACIDOPHILUS AND BIFIDOBACTERIUM BIFIDUM ON RECTAL CELL-KINETICS AND FECAL PH | 1-gen-1991 | Biasco, G; Paganelli, Gm; Brandi, G; Brillanti, S; Lami, F; Callegari, C; Gizzi, G | - | |
| Effect of α‐interferon therapy on hepatitis C viraemia in community‐acquired chronic non‐A, non‐B hepatitis: A quantitative polymerase chain reaction study | 1-gen-1991 | Brillanti, S.; Garson, J. A.; Tuke, P. W.; Ring, C.; Briggs, M.; Masci, C.; Miglioli, M.; Barbara, L.; Tedder, R. S. | - | |
| Enhanced response to peginterferon-alpha-2a based triple therapy in previously non-responsive chronic hepatitis C: Final results of PRETTY study | 1-gen-2005 | Mangia, A.; Cimino, L.; Persico, M.; Demelia, L.; Rumi, M.; Spinzi, G.; Fatuzzo, F.; Levrero, M.; Frugiuele, P. L.; Fornaciari, G.; De Stefano, G.; Venturoni, L.; Roda, Enrico; Brillanti, Stefano | - | |
| Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues—A Delphi Consensus Project | 1-gen-2022 | Borghi, C.; Ciancio, A.; Gentile, I.; Perrone Filardi, P.; Pasqualetti, P.; Brillanti, S. | - | |
| HCV INFECTION AND CHRONIC ACTIVE HEPATITIS IN ALCOHOLICS | 1-gen-1992 | Brillanti, S; Masci, C; Siringo, S; Difebo, G; Miglioli, M; Barbara, L | - | |
| Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis | 1-gen-1992 | Garson, J. A.; Brillanti, S.; Ring, C.; Perini, P.; Miglioli, M.; Barbara, L. | - | |
| HEPATITIS-C VIRUS - A POSSIBLE CAUSE OF CHRONIC HEPATITIS IN ALCOHOLICS | 1-gen-1989 | Brillanti, S; Barbara, L; Miglioli, M; Bonino, F | - |